Advances in mechanisms of Tongxinluo Capsule in treatment of ischemic stroke / 中草药
Chinese Traditional and Herbal Drugs
;
(24): 2321-2326, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-852760
ABSTRACT
Globally, stroke is the second leading cause of death and a major global disability. In China, it has exceeded heart disease to become the leading cause of death. Thus, it is urgent to prevent and treat stroke, particularly ischemic stroke. At present, except the tissue plasminogen activator (tPA) only therapy for ischemic stroke with proven efficacy, the others still lack evidence of evidence-based medicine or their curative effects are insufficient. However, in recent years, Chinese medicine, such as Tongxinluo Capsule, in treatment of ischemic stroke has attracted extensive attention. This article reviewed the research progress in mechanisms of Tongxinluo Capsule in treatment of ischemic stroke from two aspects vascular protection and neuroprotection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Traditional and Herbal Drugs
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS